Anti‑leishmanial compounds from microbial metabolites: a promising source

Leishmania is a complex disease caused by the protozoan parasites and transmitted by female phlebotomine sandfly. The disease affects some of the poorest people on earth with an estimated 700,000 to 1 million new cases annually. The current treatment for leishmaniasis is toxic, long, and limited, in...

Full description

Bibliographic Details
Main Author: Cunha, Ana F. S. da (author)
Other Authors: Di C. Oliveira, Yvanna L. (author), Dolabella, Silvio S. (author), Scher, Ricardo (author), Souto, Eliana B. (author), Lopez, Jorge A. (author), Jain, Sona (author)
Format: article
Language:eng
Published: 2021
Subjects:
Leishmaniasis
Secondary metabolites
Bioactive compounds
Microbial metabolites
Scientific database
Science & Technology
Online Access:http://hdl.handle.net/1822/74646
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/74646

Internet

http://hdl.handle.net/1822/74646

Similar Items